Mes. Eye (Lond). 2013;27:72?. 4. Lange CA, Membrey L, Ahmad N, Wickham L, Maclaren RE, Solebo L, et al. Pilot randomised controlled trial of face-down positioning following macular hole surgery. Eye (Lond). 2012;26:272?. 5. Carvounis PE, Kopel AC, Kuhl DP, Heffez J, Pepple K, Holz ER. 25-gauge vitrectomy using sulfur hexafluoride and no prone positioning for repair of macular holes. Retina. 2008;28:1188?2. 6. Rizzo S, Genovesi-Ebert F, Murri S, Belting C, Vento A, Cresti F, et al. 25-gauge, sutureless vitrectomy and standard 20-gauge pars plana vitrectomy in idiopathic epiretinal membrane surgery: A comparative pilot study. Graefes Arch Clin Exp s40337-016-0117-z Ophthalmol. 2006;244:472?. 7. Hikichi T, Kosaka S, Takami K, Ariga H, Ohtsuka H, Higuchi M, et al. 23- and 20-gauge vitrectomy with air tamponade with combined phacoemulsification for idiopathic macular hole: A single-surgeon study. Am J Ophthalmol. 2011;152:114?1. e1. 8. Goncu T, Gurelik G, Hasanreisoglu B. Comparison of efficacy and safety between transconjunctival 23-gauge and conventional 20-gauge vitrectomy systems in macular surgery. Korean J Ophthalmol. 2012;26:339?6. 9. Guillaubey A, Malvitte L, Lafontaine PO, Jay N, Hubert I, Bron A, et al. Comparison of face-down and seated position after idiopathic macular hole 1-(4-Bromo-2-pyridyl)piperazine surgery: A randomized clinical trial. Am J Ophthalmol. Methyl 2-((4-nitro-1h-pyrazol-1-yl)methyl)benzoate 2008;146:128?4. 10. Luckie A, Heriot W. Macular holes. pathogenesis, natural history and surgical outcomes. Aust N Z J Ophthalmol. 1995;23:93?00. 11. Duker JS, Kaiser PK, Binder SD, De Smet M, Gaudric A, Reichel E, et al. The international vitreomacular traction study group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology. 2013;120:2611?. 12. Wu D, Ho LY, Lai M, Capone Jr A. Surgical outcomes of idiopathic macular hole repair with limited postoperative positioning. Retina. 2011;31:609?1. 13. Rizzo S, Belting C, Cresti F, Genovesi-Ebert F. Sutureless 25-gauge vitrectomy for idiopathic macular hole repair. Graefes Arch Clin Exp Ophthalmol. 2007;245:1437?0. 14. Kim SS, Smiddy WE, Feuer WJ, Shi W. Outcomes of sulfur hexafluoride (SF6) versus perfluoropropane (C3F8) gas tamponade for macular hole surgery. Retina. 2008;28:1408?5. 15. Kusuhara S, Ooto S, Kimura D, Itoi K, Mukuno H, Miyamoto N, et al. Outcomes of 23- and 25-gauge transconjunctival sutureless vitrectomies for idiopathic macular holes. Br J Ophthalmol. 2008;92:1261?. 16. Gupta B, Laidlaw DA, Williamson TH, Shah SP, Wong R, Wren S. Predicting visual success in macular hole surgery. Br J Ophthalmol. PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/13485127 2009;93:1488?1. 17. Sanisoglu H, Sevim MS, Aktas B, Sevim S, Nohutcu A. Outcomes of 23-gauge pars plana vitrectomy and internal limiting membrane peeling with brilliant blue in macular hole. Clin Ophthalmol. 2011;5:1177?3. 18. Xirou T, Theodossiadis PG, Apostolopoulos M, Kabanarou SA, Feretis E, Ladas ID, et al. Macular hole surgery with short-acting gas and short-duration face-down positioning. Clin Ophthalmol. 2012;6:1107?2. 19. Thompson JT, Smiddy WE, Glaser BM, Sjaarda RN, Flynn Jr HW. Intraocular tamponade duration and success of macular hole surgery. Retina. 1996;16:373?2. 20. Haritoglou C, Reiniger IW, Schaumberger M, Gass PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/22763976 CA, Priglinger SG, Kampik A. Five-year follow-up of macular hole surgery with peeling of the internal limiting membrane: Update of a prospective study. Retina. 2006;26:618?2. 21. Kwok AK, Lai TY, Wong VW. Idiopathic macular hole surgery in chinese patients: A randomised study to compare indocyanine green-assisted.